All news

Promising Approach in Treating Rectal Cancer: Rethinking Radiation Before Surgery
23 September 2023

Radiation combined with chemotherapy, also known as chemoradiotherapy, is routinely given to people with rectal cancer whose tumours can be removed...

Read

Understanding Metastatic Colorectal Cancer: A Call to Awareness on World Metastatic Colorectal Cancer Day
21 September 2023

World Metastatic Colorectal Cancer (mCRC) Day stands as a symbol of hope and determination in the face of the challenges posed by this advanced sta...

Read

Predictive Values of Blood-based RNA Signature for the FOLFIRINOX/FOLFOX Response in Advanced Pancreatic Cancer
18 July 2023

Presently, no widely recognised or established biomarkers are specifically designed to predict the effectiveness of FOLFIRINOX/FOLFOX (chemotherape...

Read

DIPLOMA Trial: Minimally Invasive Surgery is an Effective Treatment Option for Early-Stage Pancreatic Cancer
18 July 2023

A notable study, DIPLOMA, led by Abu Hilal, M.D., Ph.D., of the Istituto Ospedaliero Fondazione Poliambulanza in Brescia, Italy, involved a large c...

Read

Personalized mRNA Pancreatic Cancer Vaccine Shows Promising Results in Small Trial
18 July 2023

Messenger RNA (mRNA) vaccines – famous for preventing symptomatic infection of COVID-19—are starting to show some promise against pancreati...

Read

ESMO Study Confirms Precision Oncology Remains Largely Inaccessible to European Cancer Patients
18 July 2023

As a European umbrella organisation, DiCE is vocal in addressing the disparities associated with cancer patients’ access to precision medicin...

Read

Primary and Updated Analyses for DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer
17 July 2023

Human Epidermal Growth receptor 2 (HER2) is a protein involved in normal cell growth, found in small amounts in almost all human cells, including s...

Read

RWE Research in mCRC
17 July 2023

In a recent article published in the Future Oncology, Patient Advocates and DiCE CEO Zorana Maravic explored and enhanced the understanding of the ...

Read

Manifesto for a Healthier Europe
17 July 2023

DiCE, together with the EU Health Coalition, urges future EU leaders to prioritise health and life sciences. Ahead of next year’s European el...

Read

EU Commission Approval of Tibsovo® (Ivosidenib) in IDH1-mutated Cholangiocarcinoma
17 July 2023

The European Commission approved the use of Tibsovo® (Ivosidenib) as monotherapy for the treatment of locally advanced or metastatic cholangiocarc...

Read

Stay updated about digestive cancer news

Subscribe to our newsletter for updates about our organization, news about our members or medical news about digestive cancers.

Press

For all press inquiries, please drop us a mail.

To the press section

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.